norethindrone has been researched along with norethindrone enanthate in 175 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 76 (43.43) | 18.7374 |
1990's | 31 (17.71) | 18.2507 |
2000's | 34 (19.43) | 29.6817 |
2010's | 27 (15.43) | 24.3611 |
2020's | 7 (4.00) | 2.80 |
Authors | Studies |
---|---|
Cullins, VE | 1 |
Fotherby, K; Griffin, M; McEwan, JA; Trayner, I | 1 |
Crona, N; Enk, L; Landgren, BM; Lindberg, UB; Silfverstolpe, G | 1 |
Albornoz, H; Díaz, M; Kesserü, E; Socolsky, R | 1 |
Aydinlik, S; Etchepareborda, JJ; Kaufmann, J; von Kesserü, E | 1 |
Griffin, M; McEwan, JA | 1 |
Ge, JL; Liu, XH; Lu, FY; Mao, SM; Sang, GW; Shao, QX | 1 |
Koetsawang, S | 1 |
Shaaban, MM | 1 |
Abdel-Razik, M; al-Azzony, M; al-Kholy, G; Fahmy, K; Saad, S; Shaaraway, M; Wagdi, A | 1 |
Sapire, KE | 1 |
Meng, YX; Virutamasen, P | 1 |
Garza-Flores, J; Hall, PE; Perez-Palacios, G | 1 |
Jiang, HY; Lu, FY; Meng, YX | 1 |
Chen, AJ; Fotherby, K; Jiang, HY; Lu, FY; Meng, YX; Shao, QX; Shen, KY; Sun, DL; Yang, H; Zhang, MY | 1 |
Bretin, H; Herschkorn, P; Lasselain, J; Thebaud-Mony, A | 1 |
Artini, P; Coukos, G; Genazzani, AD; Genazzani, AR; Lattesa, AM; Nappi, C; Petraglia, F; Silferi, M; Volpe, A | 1 |
Abdel-Al, S; Chalaby, S; el-Seginy, A; Gamal-Eldin, H; Nor-Eldin, M | 1 |
Bhowmik, T; Mukherjea, M | 3 |
Alba, VM; Alvarado, G; Bassol, S; Cravioto, MC; Garza-Flores, J; Hernandez, L; Perez-Palacios, G; Recio, R; Rivera, R | 1 |
Kaunitz, AM | 1 |
Arolkar, SG; Chadha, UC; Chitlange, S; Gokral, JS; Hazari, KT; Joshi, JV; Shah, RS | 1 |
Keller, PJ | 1 |
Odlind, V | 1 |
Fraser, IS | 2 |
Liu, XH; Sang, GW | 1 |
Chinvanthannond, P; Samransamruajkit, S | 1 |
el-Faras, A; el-Sibai, FA; Ismail, AA; Rocca, M; Toppozada, M | 1 |
Rabe, T; Runnebaum, B | 1 |
Amatayakul, K; Petpoo, W; Ratanawananukul, N; Suriyanon, V; Tanthayaphinant, O; Tovanabutra, S | 1 |
Bergamaschi, M; Facchinetti, F; Genazzani, AD; Genazzani, AR; Petraglia, F; Volpe, A | 1 |
Aly, MY; Fathalla, MF; Salah, M; Salem, HT; Shaaban, MM; Thabet, AI | 1 |
Born, HJ; Hörster-Poschmann, P; Kuhl, H; Sandow, J; Stoll, W; Taubert, HD | 1 |
Shen, KY | 1 |
Anderson, J; Cravioto, MC; del Real Mora, O; Díaz Sánchez, V; Garza-Flores, J; Landeros, J; Lichtenberg, R; Pérez-Palacios, G; Rodríguez, V | 1 |
Cardenas, S; Cravioto, MC; Diaz-Sanchez, V; Garza-Flores, J; Perez-Palacios, G; Rodríguez, V | 1 |
Griffin, M; Heaton, DA; McEwan, JA | 1 |
Dhanapas, S; Leepipatpaiboon, S; Virutamasen, P | 1 |
Chang, CY; Peng, XR; Zou, JC | 1 |
Majumdar, S; Nagpaul, JP; Singh, R | 1 |
Born, HJ; Kuhl, H; Schneider, M; Schneider, R; Taubert, HD | 1 |
Ahmed, N; Akhter, H; Busca, B; Chowdhury, SM; Holck, SE; Jabeen, S; Khatoon, J; Malakar, M; Rahman, S; Rahman, SS | 1 |
Baweja, R; Bhattacharya, SK; Choudhury, SD; Datey, S; Krishna, U; Kumar, S; Manuel, M; Mehta, S; Phillips, FS; Saxena, NC | 1 |
Diethelm, P; Holck, SE; Kazi, A | 1 |
Chaudhuri, C; Dutta, SK; Mukherjea, M | 1 |
Blair, M; Elder, MG; Fotherby, K; Hamawi, A; Howard, G; Trayner, I | 1 |
Ajabor, LN; Ezimokhai, M; Izilien, MI; Jackson, M | 1 |
Benagiano, G; Primiero, FM | 1 |
Birke, LI; Holzhausen, C; Murphy, S | 1 |
Elder, MG | 1 |
Correu Azcona, S; Velasco Murillo, V | 1 |
Banerjee, SK; Baweja, R; Bhatt, RV; Chatterjee, A; Choudhury, SD; Coyaji, B; Engineer, AD; Gogoi, MP; Hingorani, V | 1 |
Lähteenmäki, P; Lähteenmäki, PL; Toivonen, J | 1 |
Abdel-Rahman, H; El-Sahwi, SY; Saleh, FM; Sallam, HN; Souka, AR; Toppozada, HK | 1 |
Cruickshank, J; McMaster, M; Weir, RJ; Wilson, ES | 1 |
Babu, S; Prema, K; Ramalakshmi, BA | 1 |
Jahan, FA; Khan, AR; Swenson, I | 1 |
Fraser, IS; Weisberg, E | 1 |
Fernández-Aparicio, MA; Medina, M; Pérez-Palacios, G; Ulloa-Aguirre, A; Zacarías-Villareal, J | 1 |
Sang, GW; Zhao, XJ | 1 |
Chávez, B; Escobar, N; Larrea, F; Lince, M; Pérez, AE; Pérez-Palacios, G; Vilchis, F | 1 |
Chaudhuri, C; Mukherjea, M | 1 |
Johannisson, E; Landgren, BM; Zalányi, S | 1 |
Etchegoyen, G; Galván, E; Landeros, J; Pérez-Palacios, G; Wolpert, E | 1 |
Elder, MG; Fotherby, K; Muggeridge, J; Towobola, O | 1 |
Correu Azcona, S; García López, E; Ortiz López, J; Velasco Murillo, V | 1 |
Abaza, MS; Kandeel, KM; Nayel, SA | 1 |
Bye, PG; Elder, M; Fotherby, K; Hamawi, A; Howard, G | 1 |
Elder, MG; Fotherby, K; Howard, G; Muggeridge, J; Yong-En, S | 1 |
Andino, N | 1 |
Fotherby, K | 1 |
Elder, MG; Fotherby, K; Hamawi, A; Howard, G; Trayner, I | 1 |
Sivin, I | 1 |
Blair, M; Bye, PG; Chen, JK; Elder, MG; Fotherby, K; Howard, G; Muggeridge, J | 1 |
Fotherby, K; Koetsawang, S | 1 |
Chowdhury, SR; Srivastava, UK | 1 |
De Cecco, L; Rainer, E; Rossato, P | 1 |
Mendiratta, R; Srivastava, UK | 1 |
Back, DJ; Breckenridge, AM; Chapman, CR; Crawford, FE; Olsen, KA; Orme, ML; Rowe, PH | 1 |
Bye, PG; Elder, M; Fotherby, K; Howard, G; Sang, GW | 1 |
Born, HJ; Franz, I; Kuhl, H; Schneider, M; Taubert, HD | 1 |
Srivastava, UK | 1 |
Nair, KM; Prasad, KV; Prema, K; Rao, BS; Sivakumar, B | 1 |
Akhter, N; Choudhury, SA | 1 |
Channiyom, K; Dusitsin, N; Leepipatpaiboon, S; Vaivanijkul, B; Virutamasen, P; Werawatgoompa, S | 1 |
Fotherby, K; Khan, FS | 1 |
Aydinlik, S; Etchepareborda, JJ; von Kesseru, E | 1 |
Günzel, P; Seibert, B | 1 |
Giwa-Osagie, OF | 1 |
Chinvanthananond, P | 1 |
d'Arcangues, C | 1 |
Affandi, B; Hadisaputra, W; Rogers, PA; Siregar, B; Wonodirekso, S | 1 |
Nair, KM; Ravinder, P; Shatrugna, V; Sivakumar, B | 1 |
Altamirano, L; Canales, JR; De Aguilar, MA; De Fung, RC; Gonzalez, JD; Grillo, AE; Leon, DA; Pozuelos, JL; Ramirez, L; Rigionni, R; Salgado, JS; Sanchez, Jdel C; Torres, L; Vallecillos, G; Zambrano, EJ; Zea, C | 1 |
Berk, M; De Jager, M; Hofmeyr, GJ; Lawrie, TA; Paiker, J; Viljoen, E | 1 |
Dakin, L; Rowlands, SC | 1 |
Diebäcker, J; Kamischke, A; Nieschlag, E | 1 |
Affandi, B; Barasila, AC; Damayanti, L; Rogers, PA; Siregar, B; Wonodirekso, S | 1 |
Kamischke, A; Nieschlag, E; Plöger, D; Venherm, S; von Eckardstein, S | 1 |
Gray, A; McFadyen, L; Smit, J; Zuma, K | 1 |
Beksinska, ME; Rees, HV; Smit, J | 1 |
Heuermann, T; Kamischke, A; Krüger, K; Nieschlag, E; Rübig, A; Schellschmidt, I; von Eckardstein, S | 1 |
Eickenberg, U; Kemper, S; Lemmnitz, G; Nieschlag, E; Rolf, C | 1 |
McFadyen, L; Preston-Whyte, E; Smit, J; Zuma, K | 1 |
Beksinska, ME; Rees, HV | 1 |
DOUGLAS, M; LORAINE, JA; STRONG, JA | 1 |
Beksinska, ME; Farley, TM; Guidozzi, F; Kleinschmidt, I; Rees, HV; Smit, JA | 1 |
Bassol, S; Canto de Cetina, TE; Cetina Canto, JA; Luna, MO | 1 |
Adil, SN; Afsar, NA; Barakzai, Q | 1 |
Africander, D; Hapgood, JP; Koubovec, D; Louw, A | 1 |
Bertaccini, A; Bremner, WJ; Costantino, A; D'Emidio, L; Ernst, M; Kirsch, B; Martorana, G; Meriggiola, MC; Morselli Labate, AM; Pelusi, G; Rudolph, I; Saad, F | 1 |
Beksinska, ME; Farley, TM; Kleinschmidt, I; Mbatha, F; Smit, JA | 1 |
Junaidi, A; Kamischke, A; Luetjens, CM; Nieschlag, E; Simoni, M; Wistuba, J; Yeung, CH | 1 |
Erren, M; Kamischke, A; Nieschlag, E; Simoni, M; Zitzmann, M | 1 |
Affandi, B | 1 |
Araújo, FF; Barbieri, M; Bortolotti de Mello Jacobucci, MS; Guazzelli, CA; Moron, AF | 1 |
Hoffman, M; Morroni, C; Moss, M; Myer, L | 1 |
Bremner, WJ; Cerpolini, S; Martorana, G; Mbizvo, MT; Meriggiola, MC; Pelusi, G; Vogelsong, KM | 1 |
Beksinska, M; Draper, BH; Hapgood, J; Hoffman, M; Morroni, C; Smit, J; Van der Merwe, L | 1 |
Bahamondes, L; dos Santos Fernandes, AM; Juliato, CT; Simões, JA; Sobreira-Lima, B; Villarreal, M | 1 |
Denny, L; Kuhn, L; Myer, L; Wright, TC | 1 |
Beksinska, ME; Farley, TM; Kleinschmidt, I; Smit, JA | 3 |
Delany, S; Dinat, N; Kleinschmidt, I; McIntyre, JA; Nkala, B; Rees, H; Smith, D | 1 |
Constant, D; Cooper, D; Hoffman, M; Kalla, AA; Micklesfield, L; Rosenberg, L; Zhang, Y | 1 |
Atabey, N; Dogan, E; Kizildag, S; Koyuncuoglu, M; Posaci, C; Saatli, B; Ulukus, EC | 1 |
Dennis, CL; Herxheimer, A; Ross, LE | 1 |
González, EA; Molina, RC; Molina, TG; Montero, AV; Oyarzún, PG; Sandoval, JZ | 1 |
Beksinska, ME; Farley, TM; Kleinschmidt, I; Rees, HV; Smit, JA | 1 |
Atashili, J; Delany, S; Kleinschmidt, I; Miller, WC; Pettifor, A; Rees, H | 1 |
Beksinska, ME; Farley, TM; Kleinschmidt, I; Milford, C; Smit, JA | 1 |
Balogun, OR; Raji, HO | 1 |
Weisberg, E | 1 |
Cerpolini, S; Costantino, A; Meriggiola, MC; Pasquali, R; Pelusi, C; Pelusi, G | 1 |
Nieschlag, E | 1 |
Ahmed, K; Chen, PL; Friedland, B; Gehret-Plagianos, M; Kwok, C; Lahteenmaki, P; Morrison, CS; Patel, S; Ramjee, G; Skoler-Karpoff, S; van de Wijgert, J | 1 |
Friderichs-Gromoll, S; Luetjens, CM; Nieschlag, E; Sandhowe-Klaverkamp, R; Semjonow, A; Simoni, M; Wistuba, J; Zitzmann, M | 1 |
Gallo, MF; Grimes, DA; Halpern, V; Lopez, LM; Nanda, K; Schulz, KF | 1 |
Damm, OS; Ehmcke, J; Luetjens, CM; Nieschlag, E; Redmann, K; Sandhowe-Klaverkamp, R; Schlatt, S; Simoni, M; Steinhoff, A; Wistuba, J | 1 |
d'Arcangues, C; Gallo, MF; Grimes, DA; Lopez, LM; Schulz, KF | 1 |
Hallett, T; McCoy, SI; Padian, N; Ralph, LJ | 1 |
Curtis, KM; Polis, CB | 1 |
Abass, MM; Abdul-Hadi, RA; Aiyenigba, BO; Chabikuli, ON; Hamelmann, C; Ibrahim, MD; Ladipo, OA; Odafe, S; Oseni, LO | 1 |
Avenant, C; Govender, Y; Hapgood, JP; Ray, RM; Tomasicchio, M | 1 |
Cooney, R; Hayward, P | 1 |
Blanchard, K; Chipato, T; Harper, CC; Nhemachena, T; Ramjee, G | 1 |
Curtis, KM; Hannaford, P; Phillips, SJ; Polis, CB; Raymond, E; Steyn, PS; Turner, AN; Westreich, DJ | 1 |
Baeten, JM; Brown, J; Chen, PL; Crook, AM; Delany-Moretlwe, S; Francis, SC; Friedland, BA; Hayes, RJ; Heffron, R; Kapiga, S; Karim, QA; Karpoff, S; Kaul, R; Kwok, C; Low, N; McClelland, RS; McCormack, S; McGrath, N; Morrison, CS; Myer, L; Rees, H; Stalter, R; Van Damme, L; van de Wijgert, JH; van der Straten, A; Watson-Jones, D | 1 |
Baeten, JM; Balkus, JE; Bunge, K; Chirenje, ZM; Gomez, K; Hillier, SL; Marrazzo, JM; Nair, G; Noguchi, LM; Palanee-Phillips, T; Parikh, UM; Piper, JM; Ramjee, G; Richardson, BA; Selepe, P; van der Straten, A; Watts, DH | 1 |
Abdellati, S; Agot, K; Ahmed, K; Cohen, M; Crucitti, T; Deese, J; Masson, L; Miller, W; Morrison, C; Van Damme, L; Wang, M | 1 |
Callahan, R; Halpern, V; Nanda, K; Yacobson, I | 1 |
Gollub, EL; Jones, HE; Ralph, LJ | 1 |
Bergel, E; Hofmeyr, GJ; Lawrie, TA; Singata-Madliki, M; Temmerman, M | 1 |
Anderson, RA; Behre, HM; Callahan, MM; Colvard, DS; Festin, MP; Habib, NA; Handelsman, DJ; Lestari, SW; Linton, KA; McLachlan, RI; Meriggiola, MC; Misro, MM; Noe, G; Vogelsong, KM; Wu, FC; Zitzmann, M | 1 |
Baeten, JM; Balkus, JE; Brown, ER; Chappell, C; Harkoo, I; Jeenarain, N; Kabwigu, S; Kintu, K; Kiweewa, FM; Marzinke, M; Naidoo, L; Nair, G; Nakabiito, C; Palanee-Phillips, T; Reddy, K; Siva, S; Soto-Torres, L | 1 |
Bahall, M; Santlal, M | 1 |
Achilles, SL; Austin, MN; Chirenje, ZM; Hillier, SL; Meyn, LA; Mhlanga, F | 1 |
Balle, C; Bekker, LG; Bosinger, SE; Galmieldien, H; Gill, K; Happel, AU; Jaspan, HB; Jaumdally, SZ; Konstantinus, IN; Masson, L; Myer, L; Passmore, JS; Pidwell, T; Sinkala, M; Tanko, RF | 1 |
Achilles, SL; Chirenje, ZM; Hillier, SL; Maramba, A; Matubu, A; Mbizvo, M; Meyn, LA; Mhlanga, F; Stoner, KA | 1 |
Aceves, KM; Cherpes, TL; Gabriel, JM; Hatfield, AM; Kaur, B; Kwiek, JJ; Quispe Calla, NE; Torres, AR; Trout, W; Vicetti Miguel, RD | 1 |
Balle, C; Barnabas, SL; Bekker, LG; Esra, R; Gamieldien, H; Gill, K; Happel, AU; Jaspan, HB; Jaumdally, SZ; Konstantinus, IN; Lennard, K; Lesosky, M; Maseko, V; Myer, L; Passmore, JS; Pidwell, T | 1 |
Balle, C; Barnabas, SL; Bekker, LG; Bosinger, SE; Brodie, E; Esra, R; Gamieldien, H; Gill, K; Happel, AU; Havyarimana, E; Jaspan, HB; Jaumdally, SZ; Karaoz, U; Konstantinus, IN; Lennard, K; Maseko, V; Moodie, Z; Myer, L; Passmore, JS; Pidwell, T | 1 |
Achilles, SL; Chirenje, ZM; Hillier, SL; Maramba, A; Matubu, AT; Mbizvo, M; Meyn, LA; Mhlanga, F; Stoner, KA | 1 |
Baeten, JM; Balle, C; Bekker, LG; Brown, BP; Bunjun, R; Dabee, S; Feng, C; Gill, K; Happel, AU; Heffron, R; Jaspan, HB; Jaumdally, SZ; Konstantinus, IN; Nair, G; Onono, M; Palanee-Phillips, T; Passmore, JS; Tanko, RF | 1 |
23 review(s) available for norethindrone and norethindrone enanthate
Article | Year |
---|---|
Injectable and implantable contraceptives.
Topics: Capsules; Contraceptive Agents, Female; Drug Implants; Humans; Injections; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Microspheres; Norethindrone | 1992 |
The injectable contraceptive: present and future trends.
Topics: Contraception; Contraceptive Agents, Female; Female; Humans; Injections, Intramuscular; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone | 1991 |
Long-acting hormonal contraceptives for women.
Topics: Aniline Compounds; Contraceptive Agents, Female; Delayed-Action Preparations; Drug Implants; Female; Humans; Levonorgestrel; Norethindrone; Norethindrone Acetate; Ovulation | 1991 |
Injectable contraception.
Topics: Contraceptive Agents, Female; Delayed-Action Preparations; Female; Humans; Injections, Intramuscular; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone | 1989 |
[Hormonal contraception using depot preparations].
Topics: Abnormalities, Drug-Induced; Blood Coagulation; Carbohydrate Metabolism; Cardiovascular Diseases; Contraceptive Agents, Female; Delayed-Action Preparations; Female; Humans; Infant, Newborn; Levonorgestrel; Liver; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms; Norethindrone; Norgestrel; Pregnancy; Risk | 1986 |
New delivery systems for hormonal contraception.
Topics: Contraceptive Agents, Female; Drug Implants; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Norgestrel; Pregnancy; Progesterone; Progestins; Research; Time Factors; Vagina | 1986 |
Long acting contraceptives. Present status.
Topics: Animals; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Delayed-Action Preparations; Drug Combinations; Drug Implants; Estradiol Congeners; Female; Humans; Injections; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Progestins | 1983 |
A comprehensive review of injectable contraception with special emphasis on depot medroxyprogesterone acetate.
Topics: Australia; Blood Pressure; Breast Neoplasms; Contraceptives, Oral; Drug Implants; Female; Fertility; Fetus; Humans; Injections; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation Disturbances; Neoplasms; Norethindrone; Thrombophlebitis; Uterine Cervical Neoplasms | 1981 |
Animal toxicity studies performed for risk assessment of the once-a-month injectable contraceptive Mesigyna.
Topics: Animals; Contraceptive Agents, Female; Delayed-Action Preparations; Drug Combinations; Estradiol; Humans; Injections, Intramuscular; Neoplasms, Experimental; Norethindrone; Risk Factors | 1994 |
Metabolic effects of once-a-month combined injectable contraceptives. The World Health Organization Task Force on Long-Acting Systemic Agents for Fertility Regulation, Geneva, Switzerland.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Algestone Acetophenide; Carbohydrate Metabolism; Contraceptive Agents, Female; Estradiol; Female; Hemostasis; Humans; Hydroxyprogesterones; Injections; Lipid Metabolism; Medroxyprogesterone Acetate; Norethindrone | 1994 |
Current status of injectable hormonal contraception, with special reference to the monthly method.
Topics: Contraceptive Agents, Female; Female; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Menstruation Disturbances; Norethindrone; Pregnancy | 1997 |
Not all progestins are the same: implications for usage.
Topics: Contraceptives, Oral, Synthetic; Humans; Medroxyprogesterone; Norethindrone; Progesterone Congeners; Structure-Activity Relationship | 2004 |
Depot medroxyprogesterone versus norethisterone oenanthate for long-acting progestogenic contraception.
Topics: Contraception; Contraceptive Agents, Female; Delayed-Action Preparations; Drug Administration Schedule; Female; Humans; Medroxyprogesterone Acetate; Norethindrone; Randomized Controlled Trials as Topic | 2006 |
Oestrogens and progestins for preventing and treating postpartum depression.
Topics: Depression, Postpartum; Estrogens; Female; Humans; Norethindrone; Progestins; Randomized Controlled Trials as Topic | 2008 |
The struggle for male hormonal contraception.
Topics: Azoospermia; Clinical Trials as Topic; Contraception; Contraceptive Agents, Male; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Male; Medroxyprogesterone Acetate; Norethindrone; Pregnancy; Pregnancy Rate; Progesterone Congeners; Progestins; Testosterone | 2011 |
Steroid hormones for contraception in men.
Topics: Azoospermia; Contraception; Contraceptive Agents, Male; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Desogestrel; Drug Implants; Humans; Levonorgestrel; Male; Norethindrone; Oligospermia; Randomized Controlled Trials as Topic; Testosterone | 2012 |
Combination injectable contraceptives for contraception.
Topics: Algestone; Contraception; Contraceptive Agents, Female; Drug Combinations; Estradiol; Female; Humans; Injections; Medication Adherence; Medroxyprogesterone; Megestrol Acetate; Norethindrone; Randomized Controlled Trials as Topic | 2013 |
Use of hormonal contraceptives and HIV acquisition in women: a systematic review of the epidemiological evidence.
Topics: Aniline Compounds; Condoms, Female; Contraception; Contraceptives, Oral, Hormonal; Databases, Factual; Female; HIV Infections; Humans; Maternal Mortality; Norethindrone; Pregnancy; Pregnancy Rate; Reproducibility of Results; Risk Factors | 2013 |
Differential glucocorticoid receptor-mediated effects on immunomodulatory gene expression by progestin contraceptives: implications for HIV-1 pathogenesis.
Topics: Africa South of the Sahara; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Female; HIV Infections; HIV-1; Humans; Immunosuppression Therapy; Medroxyprogesterone Acetate; Norethindrone; Progesterone Congeners; Receptors, Glucocorticoid | 2014 |
Hormonal contraceptive methods and risk of HIV acquisition in women: a systematic review of epidemiological evidence.
Topics: Administration, Oral; Africa; Condoms; Contraceptive Agents, Female; Female; HIV Infections; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Norethindrone | 2014 |
Hormonal contraception and the risk of HIV acquisition: an individual participant data meta-analysis.
Topics: Adolescent; Adult; Africa South of the Sahara; Contraceptive Agents, Female; Female; HIV Infections; Humans; Incidence; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Risk Factors | 2015 |
Ectopic pregnancy with use of progestin-only injectables and contraceptive implants: a systematic review.
Topics: Contraception; Contraceptive Agents, Female; Desogestrel; Drug Implants; Female; Humans; Incidence; Injections; Levonorgestrel; Medroxyprogesterone Acetate; Norethindrone; Pregnancy; Pregnancy, Ectopic; Progestins | 2015 |
Hormonal contraceptive use and women's risk of HIV acquisition: priorities emerging from recent data.
Topics: Adult; Contraceptive Agents, Female; Female; Health Knowledge, Attitudes, Practice; Health Priorities; HIV Infections; Humans; Incidence; Medroxyprogesterone Acetate; Norethindrone; Public Health; Risk Assessment; Risk Factors; Sexual Behavior | 2015 |
47 trial(s) available for norethindrone and norethindrone enanthate
Article | Year |
---|---|
Serum lipid variations in women on copper intrauterine devices, triphasic oral contraceptives and monthly injectable contraceptives.
Topics: Adult; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral; Drug Combinations; Estradiol; Estrogens, Conjugated (USP); Female; Humans; Intrauterine Devices, Copper; Lipids; Longitudinal Studies; Norethindrone; Norpregnenes; Prospective Studies; Time Factors; Triglycerides | 1991 |
A multicentred, two-year, phase III clinical trial of norethisterone enanthate 50 mg plus estradiol valerate 5 mg as a monthly injectable contraceptive.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Drug Therapy, Combination; Dysmenorrhea; Estradiol; Family Planning Services; Female; Humans; Incidence; Injections; Menorrhagia; Menstrual Cycle; Norethindrone; Time Factors | 1991 |
Contraception with progestogens and progesterone during lactation.
Topics: Contraceptive Devices, Female; Humans; Infant Nutritional Physiological Phenomena; Infant, Newborn; Lactation; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Milk, Human; Norethindrone; Progesterone; Psychophysiology | 1991 |
Effect of long-acting progestagen-only injectable contraceptives on carbohydrate metabolism and its hormonal profile.
Topics: Blood Glucose; Carbohydrate Metabolism; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Delayed-Action Preparations; Female; Growth Hormone; Humans; Hydrocortisone; Insulin; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Pyruvates; Radioimmunoassay; Time Factors | 1991 |
A study of bleeding patterns with two injectable contraceptives given postpartum and the effect of two non-hormonal treatments.
Topics: Contraceptive Agents, Female; Double-Blind Method; Female; Humans; Injections; Medroxyprogesterone; Medroxyprogesterone Acetate; Naproxen; Norethindrone; Postpartum Period; Pregnancy; Tranexamic Acid; Uterine Hemorrhage | 1991 |
A multicentre phase III comparative study of two hormonal contraceptive preparations NET-OEN (50 mg) + E2 valerate (5 mg) given every month and NET-OEN (200 mg) given every 2 months as intramuscular injection--a report of 12-month study. Indian Council of
Topics: Adolescent; Adult; Contraceptives, Oral, Synthetic; Drug Administration Schedule; Drug Combinations; Estradiol; Estrogens, Conjugated (USP); Female; Humans; Injections, Intramuscular; Menstruation; Multicenter Studies as Topic; Norethindrone; Patient Dropouts; Randomized Controlled Trials as Topic | 1990 |
Hemostatic changes in women using a monthly injectable contraceptive for one year.
Topics: Adult; Blood Coagulation; Contraceptive Agents, Female; Estradiol; Factor VIII; Factor X; Female; Fibrinogen; Follicular Phase; Hemoglobins; Humans; Injections, Intramuscular; Leukocyte Count; Longitudinal Studies; Luteal Phase; Norethindrone; Prospective Studies; Prothrombin Time | 1990 |
Estrogen-progestogen once-a-month injectable contraceptives and serum prolactin.
Topics: Adult; Algestone Acetophenide; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Delayed-Action Preparations; Estradiol; Female; Humans; Injections; Intrauterine Devices, Copper; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Prolactin; Random Allocation | 1989 |
A study of adrenal corticol function and its reserve activity in long-acting injectable contraceptive users.
Topics: Adrenal Cortex; Adult; Blood Glucose; Contraceptive Agents, Female; Drug Evaluation; Female; Humans; Hydrocortisone; Hypoglycemia; Injections, Intravenous; Insulin; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone | 1988 |
Acceptability of injectable contraceptives in Assiut, Egypt.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Drug Evaluation; Egypt; Female; Humans; Injections, Intramuscular; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation Disturbances; Norethindrone; Pregnancy; Pregnancy, Unwanted | 1988 |
ICMR (Indian Council of Medical Research) Task Force on Hormonal Contraception. Return of fertility following discontinuation of an injectable contraceptive--norethisterone oenanthate (NET EN) 200mg dose. Council of Medical Research.
Topics: Adult; Clinical Trials as Topic; Contraceptive Agents, Female; Female; Fertility; Humans; India; Injections; Norethindrone | 1986 |
Indian Council of Medical Research. Task Force on Hormonal Contraception: Phase II randomized clinical trial with norethisterone oenanthate 50 mg alone and in combination with 5 mg or 2.5 mg of either estradiol valerate or cypionate as a monthly injectabl
Topics: Adult; Amenorrhea; Blood Pressure; Body Weight; Clinical Trials as Topic; Contraceptive Agents, Female; Estradiol; Female; Humans; Injections; Menstruation; Menstruation Disturbances; Norethindrone; Oligomenorrhea; Random Allocation; Time Factors | 1985 |
Phase IV study of the injection Norigest in Pakistan.
Topics: Adolescent; Adult; Amenorrhea; Clinical Trials as Topic; Contraceptive Agents, Female; Female; Humans; Injections; Menstruation Disturbances; Norethindrone; Pakistan; Parity; Time Factors | 1985 |
Effect of norethisterone enanthate on the blood count and endometrial histology of Indian women.
Topics: Blood Cells; Clinical Trials as Topic; Contraceptive Agents, Female; Endometrium; Eosinophils; Erythrocyte Count; Female; Hemoglobins; Humans; Injections; Leukocyte Count; Norethindrone; Time Factors | 1985 |
Multinational comparative clinical trial of long-acting injectable contraceptives: norethisterone enanthate given in two dosage regimens and depot-medroxyprogesterone acetate. Final report.
Topics: Adult; Amenorrhea; Clinical Trials as Topic; Contraception; Contraceptive Agents, Female; Delayed-Action Preparations; Drug Administration Schedule; Female; Fertility; Humans; Injections; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Pregnancy | 1983 |
Comparative evaluation of contraceptive efficacy of norethisterone oenanthate (200 mg) injectable contraceptive given every two or three monthly. Indian Council of Medical Research Task Force on Hormonal Contraception.
Topics: Adult; Body Weight; Clinical Trials as Topic; Contraceptive Agents, Female; Drug Administration Schedule; Female; Fertility; Humans; India; Injections, Intramuscular; Norethindrone; Pregnancy; Risk | 1984 |
A prospective controlled study of the effect on blood pressure of contraceptive preparations containing different types and dosages of progestogen.
Topics: Adolescent; Adult; Blood Pressure; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Ethinyl Estradiol; Ethynodiol Diacetate; Female; Humans; Levonorgestrel; Middle Aged; Norethindrone; Norethindrone Acetate; Norgestrel; Prospective Studies; Stereoisomerism | 1984 |
A randomized, single blind comparative trial of norethindrone enanthate and depo-medroxyprogesterone acetate in Bangladesh.
Topics: Adult; Amenorrhea; Bangladesh; Clinical Trials as Topic; Female; Humans; Injections, Intramuscular; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation Disturbances; Norethindrone; Pregnancy; Random Allocation | 1980 |
WHO special programme of research, development and research training in human reproduction. Task force on long-acting agents for the regulation of fertility.
Topics: Amenorrhea; Body Weight; Clinical Trials as Topic; Contraceptive Agents, Female; Delayed-Action Preparations; Drug Administration Schedule; Female; Humans; Injections, Intravenous; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Pregnancy; World Health Organization | 1982 |
Effects of synthetic steroid contraceptives on biliary lipid composition of normal Mexican women.
Topics: Adult; Bile; Bile Acids and Salts; Cholesterol; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Humans; Lipids; Mexico; Norethindrone; Norgestrel; Phosphatidylcholines; Prospective Studies; Random Allocation | 1983 |
Phase I clinical trial of two contraceptive preparations. Norethisterone enanthate (NEN) and norethisterone acetate (NET).
Topics: Blood Glucose; Cholesterol; Drug Evaluation; Female; Follicle Stimulating Hormone; Humans; Insulin; Kidney; Liver; Menstruation; Norethindrone; Norethindrone Acetate; Thyroid Gland; Time Factors; Triglycerides | 1981 |
Low dose injectable contraceptive norethisterone enanthate 200 mg monthly clinical trials.
Topics: Clinical Trials as Topic; Female; Humans; Norethindrone; Pregnancy | 1981 |
A clinical trial of norethisterone oenanthate (Norigest) injected every two months.
Topics: Amenorrhea; Blood Pressure; Body Weight; Clinical Trials as Topic; Contraceptive Agents, Female; Drug Administration Schedule; Female; Humans; Injections, Intramuscular; Menstruation; Norethindrone | 1982 |
Multicentred, phase III clinical trial of norethisterone enanthate 50 mg plus estradiol valerate 5 mg as a monthly injectable contraceptive; final three-year report.
Topics: Amenorrhea; Body Weight; Contraceptive Agents, Female; Estradiol; Female; Humans; Injections; Latin America; Norethindrone; Pregnancy; Uterine Hemorrhage | 1994 |
Progestogen-only contraceptives during lactation: I. Infant growth. World Health Organization Task force for Epidemiological Research on Reproductive Health; Special Programme of Research, Development and Research Training in Human Reproduction.
Topics: Adolescent; Adult; Anthropometry; Body Weight; Child Development; Chile; Contraceptive Agents, Female; Drug Implants; Egypt; Female; Humans; Hungary; Infant; Kenya; Lactation; Levonorgestrel; Medroxyprogesterone Acetate; Norethindrone; Pregnancy; Progestins; Prospective Studies; Thailand | 1994 |
Progestogen-only contraceptives during lactation: II. Infant development. World Health Organization, Task Force for Epidemiological Research on Reproductive Health; Special Programme of Research, Development, and Research Training in Human Reproduction.
Topics: Adolescent; Adult; Child Development; Chile; Contraceptive Agents, Female; Drug Implants; Egypt; Female; Humans; Hungary; Infant; Kenya; Lactation; Levonorgestrel; Medroxyprogesterone Acetate; Norethindrone; Pregnancy; Progestins; Prospective Studies; Thailand | 1994 |
A double-blind randomised placebo controlled trial of postnatal norethisterone enanthate: the effect on postnatal depression and serum hormones.
Topics: Adult; Contraceptives, Oral, Synthetic; Depression, Postpartum; Double-Blind Method; Estradiol; Female; Humans; Norethindrone; Postnatal Care; Pregnancy; Progesterone; Prognosis; Risk Factors; Testosterone; Uterine Hemorrhage | 1998 |
Potential of norethisterone enanthate for male contraception: pharmacokinetics and suppression of pituitary and gonadal function.
Topics: Adult; Analysis of Variance; Contraceptive Agents, Male; Depression, Chemical; Humans; Libido; Luteinizing Hormone; Male; Norethindrone; Pituitary Gland; Prostate; Sex Hormone-Binding Globulin; Sexuality; Sperm Count; Testis; Testosterone; Ultrasonography | 2000 |
Intramuscular testosterone undecanoate and norethisterone enanthate in a clinical trial for male contraception.
Topics: Adult; Alkaline Phosphatase; Contraceptive Agents, Male; Drug Combinations; Follicle Stimulating Hormone; Humans; Injections, Intramuscular; Lipids; Luteinizing Hormone; Male; Norethindrone; Prostate; Semen; Sexual Behavior; Sperm Count; Sperm Motility; Testis; Testosterone; Ultrasonography | 2001 |
An effective hormonal male contraceptive using testosterone undecanoate with oral or injectable norethisterone preparations.
Topics: Administration, Oral; Adult; Blood; Coitus; Contraceptive Agents, Male; Contraceptives, Oral, Synthetic; Drug Synergism; Hormones; Humans; Injections, Intramuscular; Lipids; Male; Middle Aged; Norethindrone; Prostate; Sperm Count; Spermatogenesis; Testis; Testosterone; Testosterone Congeners | 2002 |
Pharmacokinetics of a new transdermal testosterone gel in gonadotrophin-suppressed normal men.
Topics: Adult; Dose-Response Relationship, Drug; Gels; Gonadotropins; Hormone Replacement Therapy; Humans; Injections, Intramuscular; Male; Norethindrone; Testosterone | 2002 |
Menstrual pattern and lipid profiles during use of medroxyprogesterone acetate and estradiol cypionate and NET-EN (200 mg) as contraceptive injections.
Topics: Adolescent; Adult; Cholesterol; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Female; Humans; Injections, Intramuscular; Lipids; Medroxyprogesterone Acetate; Menstruation Disturbances; Middle Aged; Norethindrone | 2004 |
Use of norethisterone oenanthate and predisposition to thrombosis.
Topics: Adult; Blood Coagulation; Blood Coagulation Tests; Contraceptive Agents, Female; Female; Humans; Middle Aged; Norethindrone; Pakistan | 2004 |
Norethisterone enanthate plus testosterone undecanoate for male contraception: effects of various injection intervals on spermatogenesis, reproductive hormones, testis, and prostate.
Topics: Adolescent; Adult; Contraception; Drug Combinations; Follicle Stimulating Hormone; Humans; Injections; Luteinizing Hormone; Male; Middle Aged; Norethindrone; Prospective Studies; Prostate; Sperm Count; Spermatogenesis; Testis; Testosterone | 2005 |
Acceptability of an injectable male contraceptive regimen of norethisterone enanthate and testosterone undecanoate for men.
Topics: Adult; Affect; Attitude; Contraception Behavior; Contraceptive Agents, Male; Drug Combinations; Humans; Injections, Intramuscular; Male; Norethindrone; Patient Acceptance of Health Care; Sexual Behavior; Testosterone | 2006 |
Prospective study of hormonal contraception and women's risk of HIV infection in South Africa.
Topics: Adult; Age Distribution; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Female; HIV Infections; Humans; Incidence; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Prospective Studies; Risk Factors; Sexual Behavior; Sexually Transmitted Diseases; South Africa; Time Factors; Uterine Cervical Neoplasms | 2007 |
A placebo-controlled, randomized clinical trial using testosterone undecanoate with injectable norethisterone enanthate: effect on anthropometric, metabolic and biochemical parameters.
Topics: Adult; Anthropometry; Body Mass Index; Humans; Male; Norethindrone; Placebos; Testosterone | 2011 |
Hormonal contraception and the risk of HIV acquisition among women in South Africa.
Topics: Adolescent; Adult; Anti-Infective Agents; Contraceptives, Oral, Hormonal; Female; HIV Seropositivity; Humans; Incidence; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Odds Ratio; Pregnancy; Proportional Hazards Models; Sexual Behavior; South Africa; Vaginal Creams, Foams, and Jellies; Young Adult | 2012 |
Risk of HIV-1 acquisition among women who use diff erent types of injectable progestin contraception in South Africa: a prospective cohort study.
Topics: Adult; Cohort Studies; Contraception Behavior; Contraceptive Agents, Female; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Incidence; Medroxyprogesterone Acetate; Norethindrone; Proportional Hazards Models; Risk Factors; South Africa; Tenofovir; Young Adult | 2015 |
Effects of the copper intrauterine device versus injectable progestin contraception on pregnancy rates and method discontinuation among women attending termination of pregnancy services in South Africa: a pragmatic randomized controlled trial.
Topics: Abdominal Pain; Abortion, Legal; Adolescent; Adult; Back Pain; Contraception Behavior; Contraceptive Agents, Female; Drug Implants; Early Termination of Clinical Trials; Female; Follow-Up Studies; Humans; Intrauterine Devices, Copper; Lost to Follow-Up; Medroxyprogesterone Acetate; Norethindrone; Postoperative Period; Pregnancy; Pregnancy Rate; Progestins; South Africa; Young Adult | 2016 |
Efficacy and Safety of an Injectable Combination Hormonal Contraceptive for Men.
Topics: Adolescent; Adult; Androgens; Contraception; Contraceptive Agents; Drug Therapy, Combination; Female; Humans; Injections, Intramuscular; Male; Norethindrone; Outcome Assessment, Health Care; Pregnancy; Prospective Studies; Spermatogenesis; Testosterone; Young Adult | 2016 |
Brief Report: Dapivirine Vaginal Ring Use Does Not Diminish the Effectiveness of Hormonal Contraception.
Topics: Adolescent; Adult; Anti-Retroviral Agents; Contraception; Contraceptive Agents, Female; Contraceptive Devices, Female; Contraceptives, Oral, Hormonal; Double-Blind Method; Drug Interactions; Female; Follow-Up Studies; HIV Infections; Humans; Incidence; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Pregnancy; Pyrimidines; Young Adult | 2017 |
Impact of Hormonal Contraceptives on Cervical T-helper 17 Phenotype and Function in Adolescents: Results from a Randomized, Crossover Study Comparing Long-acting Injectable Norethisterone Oenanthate (NET-EN), Combined Oral Contraceptive Pills, and Combine
Topics: Adolescent; Africa South of the Sahara; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Cross-Over Studies; Female; Humans; Norethindrone; Phenotype; Pregnancy | 2020 |
Hormonal contraception and risk of STIs and bacterial vaginosis in South African adolescents: secondary analysis of a randomised trial.
Topics: Adolescent; Bacteria; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Cross-Over Studies; Female; Hormonal Contraception; Humans; Incidence; Intention to Treat Analysis; Norethindrone; Risk; Sexually Transmitted Diseases; South Africa; Species Specificity; Vagina; Vaginosis, Bacterial; Young Adult | 2021 |
Hormonal contraception alters vaginal microbiota and cytokines in South African adolescents in a randomized trial.
Topics: Adolescent; Africa South of the Sahara; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Cross-Over Studies; Cytokines; Female; HIV Infections; Hormonal Contraception; Humans; Microbiota; Norethindrone; RNA, Ribosomal, 16S; T-Lymphocytes; Vagina; Young Adult | 2020 |
Effect of injectable progestin-only contraceptives, depot medroxyprogesterone acetate and norethisterone enanthate, on cytokine production during T-cell activation.
Topics: CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Contraceptive Agents, Female; Female; Humans; Injections; Interferon-gamma; Intrauterine Devices, Copper; Lymphocyte Activation; Medroxyprogesterone Acetate; Norethindrone; Progestins; Young Adult | 2021 |
Comparison of Female Genital Tract Cytokine and Microbiota Signatures Induced by Initiation of Intramuscular DMPA and NET-EN Hormonal Contraceptives - a Prospective Cohort Analysis.
Topics: Adolescent; Adult; Africa South of the Sahara; Contraceptive Agents, Female; Contraceptive Agents, Hormonal; Cross-Over Studies; Cytokines; Female; Genitalia, Female; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Microbiota; Norethindrone; Prospective Studies; RNA, Ribosomal, 16S; Sexually Transmitted Diseases; Vaginosis, Bacterial; Young Adult | 2021 |
105 other study(ies) available for norethindrone and norethindrone enanthate
Article | Year |
---|---|
Long-term use of depot-norethisterone enanthate: effect on blood lipid fractions.
Topics: Adult; Blood Pressure; Cholesterol; Contraceptive Agents, Female; Female; Humans; Injections, Intramuscular; Lipids; Lipoproteins, HDL; Lipoproteins, LDL; Middle Aged; Norethindrone; Odds Ratio; Triglycerides | 1992 |
A prospective, one-year study on the effects of two long acting injectable contraceptives (depot-medroxyprogesterone acetate and norethisterone oenanthate) on serum and lipoprotein lipids.
Topics: Adult; Apolipoproteins; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Delayed-Action Preparations; Female; Humans; Injections; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Prospective Studies; Time Factors; Triglycerides | 1992 |
Long-term use of depot-norethisterone enanthate: effect on blood coagulation factors and menstrual bleeding patterns.
Topics: Adult; Amenorrhea; Antigens; Antithrombin III; Blood Coagulation Factors; Contraceptives, Oral, Synthetic; Delayed-Action Preparations; Erythrocyte Count; Erythrocyte Volume; Factor VII; Factor X; Female; Hemoglobins; Humans; Injections; Menstruation; Middle Aged; Norethindrone; Time Factors | 1991 |
[Pharmacokinetics of norethindrone enanthate 200 mg after intramuscular injection in 25 Chinese women].
Topics: Adult; Asian People; Female; Humans; Injections, Intramuscular; Norethindrone; Progesterone Congeners; White People | 1991 |
Effect of norethisterone enanthate on endometrial bleeding and changes in coagulation function, ovarian hormones and endometrial histology in Thai women.
Topics: Adult; Blood Coagulation; Contraceptive Agents, Female; Endometrium; Female; Gonadal Steroid Hormones; Humans; Menstrual Cycle; Norethindrone; Thailand | 1991 |
The effects of long-term using once-a-month injectable contraceptive norethisterone enanthate/estradiol valerate on coagulation in the Chinese.
Topics: Adult; Blood Coagulation; China; Contraceptive Agents, Female; Drug Administration Schedule; Estradiol; Female; Fibrinolysis; Humans; Injections; Longitudinal Studies; Norethindrone; Risk Factors | 1990 |
[Doctors and injectable contraception. Analysis of the logistics of prescribing in accordance with the views expressed by doctors].
Topics: Attitude of Health Personnel; Attitude to Health; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Cultural Characteristics; Family Planning Services; Female; France; Humans; Injections, Intramuscular; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Patient Care Team; Physician-Patient Relations; Practice Patterns, Physicians'; Socioeconomic Factors | 1990 |
Progestins modulate the action of estrogen on gonadotropin-releasing hormone, luteinizing hormone and prolactin in the rat.
Topics: Animals; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Desogestrel; Estrogens; Female; Luteinizing Hormone; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Norpregnenes; Pituitary Gland; Pituitary Hormone-Releasing Hormones; Progestins; Prolactin; Radioimmunoassay; Rats; Rats, Inbred Strains | 1990 |
The toxic pathophysiology of retinol hypervitaminosis and norethisterone enantate in rats.
Topics: Animals; Contraceptives, Oral, Synthetic; Female; Hypervitaminosis A; Kidney; Liver; Norethindrone; Ovary; Rats | 1990 |
Alterations in protein, sialic acid and some enzymes in cervical mucus of female rats during NET-EN treatment.
Topics: Alkaline Phosphatase; Amylases; Animals; Cervix Mucus; Contraceptives, Oral, Synthetic; Electrophoresis, Polyacrylamide Gel; Estrus; Female; Norethindrone; Proteins; Rats; Rats, Inbred Strains; Sialic Acids; Time Factors | 1987 |
Serum progesterone and norethisterone levels following injection of norethisterone enanthate in different sites and doses.
Topics: Adult; Anovulation; Contraceptives, Oral, Synthetic; Dose-Response Relationship, Drug; Female; Humans; Injections, Intramuscular; Menstruation; Norethindrone; Progesterone | 1989 |
Effect of Depo-Provera and Noristerat on some biochemical constituents of rat uterus.
Topics: Acid Phosphatase; Alkaline Phosphatase; Animals; Contraceptive Agents, Female; Female; Lipid Metabolism; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Rats; Rats, Inbred Strains; Uterus | 1986 |
Menstrual changes associated with progestogen-only contraception.
Topics: Administration, Oral; Amenorrhea; Contraceptive Agents, Female; Counseling; Estrogens; Female; Humans; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation Disturbances; Norethindrone; Norgestrel; Time Factors | 1986 |
Pharmacokinetics of norethindrone oenanthate in 5 women after a single dose of norethindrone oenanthate and estradiol valerate.
Topics: Adult; Biological Availability; Contraceptives, Oral, Synthetic; Estradiol; Female; Half-Life; Humans; Kinetics; Norethindrone | 1986 |
New regimen of injectable contraceptives.
Topics: Adult; Female; Humans; Injections, Intramuscular; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone | 1987 |
Pituitary response to LHRH in long-term users of injectable contraceptives.
Topics: Adult; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Injections; Luteinizing Hormone; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone | 1987 |
[Parenteral contraceptive drugs: depot progestins].
Topics: Administration, Intravaginal; Contraceptive Agents, Female; Delayed-Action Preparations; Drug Implants; Female; Humans; Injections; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstrual Cycle; Norethindrone; Pregnancy | 1987 |
Histological changes in the ovary and uterus of rat after injectable contraceptive therapy.
Topics: Animals; Contraception; Contraceptive Agents; Female; Injections, Subcutaneous; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Ovary; Rats; Rats, Inbred Strains; Uterus | 1988 |
Progesterone and progestins modulate beta-endorphin concentrations in the hypothalamus and in the pituitary of castrated female rats.
Topics: Animals; beta-Endorphin; Desogestrel; Estradiol; Female; Hypothalamus, Middle; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Norpregnenes; Ovariectomy; Pituitary Gland; Pituitary Gland, Anterior; Progesterone; Progestins; Radioimmunoassay; Rats; Rats, Inbred Strains | 1987 |
Investigations upon the mechanism of inhibition of spermatogenesis in the rat by a dimeric ethynodiol-testosterone ester.
Topics: Androgen-Binding Protein; Animals; Ethynodiol Diacetate; Follicle Stimulating Hormone; Luteinizing Hormone; Male; Norethindrone; Rats; Rats, Inbred Strains; Spermatogenesis; Testis; Testosterone | 1988 |
[Restoration of pituitary-ovarian function after long-term application of combined norethindrone oenanthate].
Topics: Adult; Contraceptive Agents, Female; Female; Follicle Stimulating Hormone; Humans; Injections, Intramuscular; Luteinizing Hormone; Norethindrone; Ovary; Ovulation; Pituitary Gland | 1988 |
[Effectiveness of injectable contraceptives in Mexican women].
Topics: Adolescent; Adult; Contraceptive Agents, Female; Delayed-Action Preparations; Drug Evaluation; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Mexico; Norethindrone; Patient Acceptance of Health Care; Patient Dropouts; Pregnancy | 1985 |
Return to ovulation following the use of long-acting injectable contraceptives: a comparative study.
Topics: Adult; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstrual Cycle; Norethindrone; Ovulation; Progesterone; Time Factors | 1985 |
Long-term use of an injectable contraceptive: effect of depot-norethisterone oenanthate on carbohydrate metabolism.
Topics: Adult; Blood Glucose; Carbohydrate Metabolism; Delayed-Action Preparations; Fasting; Female; Glucose Tolerance Test; Humans; Insulin; Norethindrone; Time Factors | 1988 |
Serum levels of norethisterone, estradiol and progesterone after administration of norethisterone oenanthate at different sites: a cross-over study.
Topics: Adult; Estradiol; Female; Humans; Injections, Intramuscular; Kinetics; Norethindrone; Progesterone | 1987 |
[Effect of progesterone and norethisterone oenanthate on dynamic distribution of progesterone receptor in target cell].
Topics: Animals; Cell Nucleus; Contraceptives, Oral, Synthetic; Female; Norethindrone; Progesterone; Rabbits; Receptors, Progesterone; Uterus | 1987 |
Effect of norethisterone enanthate on intestinal digestive and absorptive functions in protein deficient rat.
Topics: Animals; Digestion; Female; Intestinal Absorption; Microvilli; Norethindrone; Protein Deficiency; Rats | 1987 |
Dose- and time-dependent effects of a dimeric ethynodiol-testosterone depot-preparation in female rat.
Topics: Animals; Castration; Dose-Response Relationship, Drug; Drug Implants; Estradiol; Ethynodiol Diacetate; Female; Luteinizing Hormone; Norethindrone; Organ Size; Ovary; Pituitary Gland; Progesterone; Rats; Structure-Activity Relationship; Testosterone; Thymus Gland; Time Factors | 1985 |
Introduction of the injectable contraceptive NET-EN into family planning clinics in Bangladesh.
Topics: Adolescent; Adult; Bangladesh; Contraceptives, Oral, Synthetic; Family Planning Services; Female; Humans; Injections, Intramuscular; National Health Programs; Norethindrone | 1985 |
Some metabolic effects of long-term use of the injectable contraceptive norethisterone oenanthate.
Topics: Adult; Blood Coagulation; Cholesterol; Contraceptive Agents, Female; Cross-Sectional Studies; Female; Glucose Tolerance Test; Humans; Injections, Intramuscular; Lipoproteins, HDL; Middle Aged; Norethindrone; Time Factors; Triglycerides | 1982 |
Response of unmarried adolescents to contraceptive advice and service in Nigeria.
Topics: Adolescent; Contraception; Contraception Behavior; Contraceptive Agents, Female; Developing Countries; Family Planning Services; Female; Health Knowledge, Attitudes, Practice; Humans; Intrauterine Devices; Male; Nigeria; Norethindrone; Prospective Studies; Sex Education | 1981 |
Long-acting progestins--promise and prospects.
Topics: Animals; Bibliographies as Topic; Breast Neoplasms; Contraceptives, Oral, Combined; Delayed-Action Preparations; Dogs; Female; Haplorhini; Humans; Injections, Intramuscular; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Norgestrel; Progesterone Congeners; Rats; Reproduction; Uterine Neoplasms | 1983 |
Neonatal exposure to a progestin via milk alters subsequent LH cyclicity in the female rat.
Topics: Animals; Animals, Newborn; Animals, Suckling; Female; Luteinizing Hormone; Medroxyprogesterone; Medroxyprogesterone Acetate; Milk; Norethindrone; Pregnancy; Proestrus; Progesterone; Progestins; Rats; Rats, Inbred Strains | 1984 |
A survey of different approaches to management of menstrual disturbances in women using injectable contraceptives.
Topics: Amenorrhea; Contraceptive Agents, Female; Curettage; Estrogens; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menorrhagia; Menstruation Disturbances; Norethindrone; Oligomenorrhea | 1983 |
Injectable contraception.
Topics: Adult; Cervix Mucus; Contraceptive Agents, Female; Endometrium; Female; Humans; Injections, Intramuscular; Kinetics; Lactation; Lipid Metabolism; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Pregnancy; Uterine Hemorrhage | 1984 |
[Injectable contraception using depot progestagens].
Topics: Animals; Contraceptive Agents, Female; Delayed-Action Preparations; Dogs; Embryonic and Fetal Development; Female; Fertility; Humans; Macaca mulatta; Mammary Neoplasms, Experimental; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Pregnancy | 1983 |
Postabortal contraception with norethisterone enanthate injections.
Topics: Abortion, Legal; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Drug Administration Schedule; Estradiol; Female; Follicle Stimulating Hormone; Humans; Injections, Intramuscular; Luteinizing Hormone; Norethindrone; Pregnancy; Pregnancy Trimester, First; Progesterone; Time Factors | 1983 |
Blood hormone levels in egyptian women on norethisterone oenanthate.
Topics: Adult; Animals; Contraceptive Agents, Female; Egypt; Estradiol; Female; Follicle Stimulating Hormone; Gonadotropins, Pituitary; Humans; Injections; Luteinizing Hormone; Norethindrone; Ovulation; Progesterone; Prolactin; Rats | 1983 |
Serum copper and zinc in hormonal contraceptive users.
Topics: 20-alpha-Dihydroprogesterone; Contraceptive Devices, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Copper; Estradiol; Ethinyl Estradiol; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Norgestrel; Zinc | 1980 |
On the mechanism of action of progestins.
Topics: Castration; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norethindrone; Pituitary Gland; Progesterone; Progesterone Congeners; Receptors, Androgen | 1981 |
[Metabolism of [6, 7-3H] norethisterone enanthate in rats (author's transl)].
Topics: Animals; Contraceptives, Oral; Contraceptives, Oral, Hormonal; Female; Metabolic Clearance Rate; Norethindrone; Rats; Tissue Distribution; Tritium | 1981 |
Mechanism of action of contraceptive synthetic progestins.
Topics: Androgen-Insensitivity Syndrome; Animals; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Norethindrone; Ovary; Rabbits; Rats; Receptors, Steroid; Sheep | 1981 |
Studies on some enzymes and sialic acid during progestational contraceptive therapy.
Topics: Acetylcholinesterase; Acid Phosphatase; Adult; Alanine Transaminase; Alkaline Phosphatase; Aspartate Aminotransferases; Enzymes; Female; Humans; Liver; N-Acetylneuraminic Acid; Norethindrone; Sialic Acids | 1984 |
Pharmacokinetics, pharmacodynamic and endometrial effects of a single dose of 200 mg norethisterone enanthate.
Topics: Adult; Endometrium; Female; Humans; Injections, Intramuscular; Kinetics; Norethindrone; Ovulation | 1984 |
Norethisterone levels in maternal serum and milk after intramuscular injection of norethisterone oenanthate as a contraceptive.
Topics: Breast Feeding; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Female; Humans; Injections, Intramuscular; Milk, Human; Norethindrone; Time Factors | 1983 |
[Use and effectiveness of norethisterone enanthate for family planning in a rural area].
Topics: Adolescent; Adult; Contraceptive Agents, Female; Delayed-Action Preparations; Drug Evaluation; Female; Health Knowledge, Attitudes, Practice; Humans; Injections, Intramuscular; Mexico; Norethindrone; Pregnancy; Rural Population | 1983 |
The effect of injectable contraceptive on lipid metabolism in women.
Topics: Adult; Cholesterol; Fatty Acids, Nonesterified; Female; Humans; Injections; Lipids; Norethindrone; Phospholipids; Triglycerides | 1984 |
Pharmacokinetics of different doses of norethisterone oenanthate.
Topics: Adult; Contraceptives, Oral, Synthetic; Dose-Response Relationship, Drug; Estradiol; Female; Humans; Injections, Intramuscular; Kinetics; Male; Middle Aged; Norethindrone; Ovary; Ovulation; Progesterone; Regression Analysis | 1984 |
Return of ovulation and fertility in women using norethisterone oenanthate.
Topics: Adult; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Estradiol; Female; Fertility; Humans; Menstruation; Norethindrone; Ovulation; Pregnancy; Progesterone | 1984 |
Variability of pharmacokinetic parameters for contraceptive steroids.
Topics: Biological Availability; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Half-Life; Humans; Kinetics; Norethindrone | 1983 |
Effect of injectable norethisterone oenanthate (Norigest) on blood lipid levels.
Topics: Adult; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Contraceptive Agents, Female; Female; Humans; Lipids; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Middle Aged; Norethindrone; Obesity; Smoking | 1982 |
Metabolism of injectable formulations of contraceptive steroids in obese and thin women.
Topics: Adult; Estradiol; Female; Humans; Injections, Intramuscular; Medroxyprogesterone; Norethindrone; Obesity; Progesterone; Time Factors | 1982 |
Effect of norethisterone enanthate subdermal silastic implants on luteal function in rabbits.
Topics: Animals; Corpus Luteum; Drug Implants; Female; Norethindrone; Pregnancy; Progesterone; Rabbits; Silicone Elastomers | 1982 |
Effectiveness of norethisterone enantate in the treatment of the climacteic syndrome.
Topics: Adult; Climacteric; Female; Gonadotropins; Humans; Middle Aged; Norethindrone; Prolactin | 1982 |
Effect of norethisterone enanthate subdermal silastic implants on the ovary & uterus of adult rabbits.
Topics: Animals; Drug Implants; Female; Norethindrone; Ovary; Rabbits; Silicone Elastomers; Uterus | 1980 |
Studies on the enzymatic cleavage of norethisterone oenanthate.
Topics: Adipose Tissue; Adult; Aged; Animals; Dogs; Female; Gastric Mucosa; Goats; Humans; Hydrolysis; Intestinal Mucosa; Kidney; Liver; Male; Middle Aged; Muscles; Norethindrone; Organ Specificity; Rabbits; Rats; Species Specificity | 1981 |
Pharmacokinetics of norethisterone oenanthate in humans.
Topics: Absorption; Adolescent; Adult; Biological Availability; Female; Half-Life; Humans; Kinetics; Male; Norethindrone | 1981 |
Reversible inhibition of spermatogenesis by a long-acting dimeric ethynodiol-testosterone ester.
Topics: Animals; Antispermatogenic Agents; Dose-Response Relationship, Drug; Ethynodiol Diacetate; Female; Genitalia, Male; Kinetics; Luteinizing Hormone; Male; Norethindrone; Organ Size; Rabbits; Rats; Spermatogenesis; Testis; Testosterone | 1981 |
Contraceptive efficacy of microdose norethisterone enanthate: a study on its use in polydimethylsiloxane implants.
Topics: Animals; Dimethylpolysiloxanes; Drug Implants; Female; Norethindrone; Ovulation; Rabbits | 1981 |
Plasma levels of norethidrone in Indian women receiving norethidrone enanthate (20 mg) injectable.
Topics: Adult; Anthropometry; Body Weight; Female; Humans; India; Injections, Intramuscular; Norethindrone; Ovulation; Progesterone | 1981 |
Effect of norethisterone oenanthate-a long acting injectable contraceptive on cervical mucus changes in adult female virgin rats.
Topics: Animals; Cervix Mucus; Female; Norethindrone; Proteins; Rats | 1981 |
The effect of injectable norethisterone oenanthate on ovarian hormones in Thai women.
Topics: Adult; Contraceptives, Oral, Combined; Estradiol; Ethinyl Estradiol; Female; Humans; Injections, Intramuscular; Norethindrone; Norgestrel; Ovulation; Progesterone | 1980 |
In vitro hydrolysis of 19-norsteroid esters.
Topics: Adipose Tissue; Animals; Hydrolysis; In Vitro Techniques; Intestine, Small; Kidney; Liver; Lung; Lynestrenol; Muscles; Myocardium; Norethindrone; Norethindrone Acetate; Norgestrel; Norsteroids; Rabbits | 1980 |
Endometrial pattern in long-term users of NET-EN.
Topics: Adult; Biopsy; Contraceptives, Oral, Synthetic; Endometrium; Female; Humans; Norethindrone | 1993 |
Once-a-month injectable contraceptives.
Topics: Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Administration Schedule; Drug Combinations; Estradiol; Female; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Norethindrone | 1993 |
Cytokeratin 8, 18 and 19 in endometrial epithelium of Norplant and norethisterone enanthate injectable progestogen contraceptive users.
Topics: Adult; Animals; Antibodies, Monoclonal; Biopsy; Contraceptive Agents, Female; Endometrium; Female; Humans; Immunohistochemistry; Keratins; Levonorgestrel; Mice; Norethindrone | 1996 |
Pharmacokinetics of orally administered norethisterone enanthate in rabbit, monkey, and women.
Topics: Administration, Oral; Animals; Contraceptives, Oral, Synthetic; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Humans; Injections, Intramuscular; Macaca mulatta; Norethindrone; Rabbits; Time Factors | 1997 |
Twelve years of injectable contraceptive use in a general practice.
Topics: Adolescent; Adult; Child; Contraceptive Agents, Female; Family Practice; Female; Humans; Injections, Subcutaneous; London; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Practice Patterns, Physicians'; Progesterone Congeners; Retrospective Studies | 1998 |
Endometrial epithelial integrity and subepithelial reticular fibre expression in progestin contraceptive acceptors.
Topics: Adult; Biopsy; Collagen; Contraceptive Agents, Female; Endometrium; Epithelium; Female; Humans; Hysteroscopy; Immunohistochemistry; Keratins; Norethindrone; Progesterone Congeners; Silver Staining; Staining and Labeling; Uterine Hemorrhage | 2000 |
Counting the costs: comparing depot medroxyprogesterone acetate and norethisterone oenanthate utilisation patterns in South Africa.
Topics: Adolescent; Adult; Age Factors; Choice Behavior; Contraceptive Agents, Female; Developing Countries; Drug Costs; Drugs, Essential; Female; Fertility; Health Expenditures; Health Services Needs and Demand; Humans; Injections; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Pharmacies; South Africa; Treatment Outcome | 2001 |
Temporary discontinuation: a compliance issue in injectable users.
Topics: Adult; Cohort Studies; Contraception Behavior; Contraceptive Agents, Female; Delayed-Action Preparations; Female; Humans; Injections; Medroxyprogesterone Acetate; Norethindrone; Patient Acceptance of Health Care; Patient Compliance | 2001 |
Vaginal wetness: an underestimated problem experienced by progestogen injectable contraceptive users in South Africa.
Topics: Adolescent; Adult; Amenorrhea; Contraceptive Agents, Female; Cross-Sectional Studies; Family Characteristics; Female; Focus Groups; Health Knowledge, Attitudes, Practice; Humans; Injections, Intramuscular; Interviews as Topic; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Qualitative Research; Rural Population; Sexual Partners; South Africa; Vaginal Discharge | 2002 |
Vaginal discharge: a perceived side effect and minor reason for discontinuation in hormonal injectable users in South Africa.
Topics: Adult; Contraceptive Agents, Female; Delayed-Action Preparations; Female; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Norethindrone; Patient Compliance; South Africa; Vaginal Discharge | 2001 |
Studies with 19-norethisterone oenanthate in mammary carcinoma.
Topics: Breast; Breast Neoplasms; Humans; Norethindrone; Progesterone | 1960 |
Detection of raised FSH levels among older women using depomedroxyprogesterone acetate and norethisterone enanthate.
Topics: Adult; Biomarkers; Case-Control Studies; Cohort Studies; Contraceptives, Oral, Combined; Female; Follicle Stimulating Hormone; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norethindrone; Predictive Value of Tests | 2003 |
Bone mineral density in women aged 40-49 years using depot-medroxyprogesterone acetate, norethisterone enanthate or combined oral contraceptives for contraception.
Topics: Adult; Body Mass Index; Bone Density; Cohort Studies; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Cross-Sectional Studies; Employment; Exercise; Female; Follicle Stimulating Hormone; Humans; Marital Status; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; South Africa; Time Factors | 2005 |
Norethisterone enanthate has neither a direct effect on the testis nor on the epididymis: a study in adult male cynomolgus monkeys (Macaca fascicularis).
Topics: Animals; Body Weight; Chorionic Gonadotropin; Contraceptive Agents, Male; Epididymis; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Macaca fascicularis; Male; Norethindrone; Sperm Count; Spermatids; Spermatogenesis; Testis; Testosterone | 2005 |
Endogenous progesterone and the exogenous progestin norethisterone enanthate are associated with a proinflammatory profile in healthy men.
Topics: Adult; Androgens; Biomarkers; Contraceptive Agents, Male; Controlled Clinical Trials as Topic; Cross-Sectional Studies; Drug Synergism; Humans; Inflammation; Longitudinal Studies; Male; Middle Aged; Norethindrone; Progesterone; Progesterone Congeners; Testosterone; Testosterone Congeners | 2005 |
Injectable contraceptives: a worldwide perspective.
Topics: Animals; Contraceptive Agents, Female; Developing Countries; Female; Global Health; Humans; Injections; Medroxyprogesterone Acetate; Models, Animal; Norethindrone | 2002 |
Bleeding patterns of adolescents using a combination contraceptive injection for 1 year.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Drug Combinations; Estradiol; Female; Humans; Injections, Intramuscular; Menstruation; Menstruation Disturbances; Norethindrone; Patient Compliance; Prospective Studies | 2006 |
Preferences between injectable contraceptive methods among South African women.
Topics: Adolescent; Adult; Cross-Sectional Studies; Delayed-Action Preparations; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Patient Education as Topic; Patient Satisfaction; South Africa | 2006 |
Bone mineral density in users of two kinds of once-a-month combined injectable contraceptives.
Topics: Absorptiometry, Photon; Adult; Body Mass Index; Bone Density; Contraceptive Agents, Female; Cross-Sectional Studies; Estradiol; Female; Humans; Injections; Medroxyprogesterone Acetate; Norethindrone; Radius; Ulna | 2006 |
Bone mineral density in adolescents using norethisterone enanthate, depot-medroxyprogesterone acetate or combined oral contraceptives for contraception.
Topics: Absorptiometry, Photon; Adolescent; Adult; Bone Density; Contraceptives, Oral, Combined; Delayed-Action Preparations; Female; Humans; Longitudinal Studies; Medroxyprogesterone Acetate; Norethindrone; Surveys and Questionnaires | 2007 |
Injectable progestin contraceptive use and risk of HIV infection in a South African family planning cohort.
Topics: Adolescent; Adult; Cohort Studies; Contraceptive Agents, Female; Delayed-Action Preparations; Family Planning Services; Female; HIV Infections; Humans; Incidence; Medroxyprogesterone; Norethindrone; Prevalence; South Africa | 2007 |
Bone status after cessation of use of injectable progestin contraceptives.
Topics: Adolescent; Adult; Ambulatory Care Facilities; Black People; Bone Density; Bone Resorption; Calcaneus; Contraceptive Agents, Female; Cross-Sectional Studies; Delayed-Action Preparations; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Norethindrone; South Africa; Ultrasonography | 2007 |
Long-term effects of GnRH agonist, GnRH antagonist, and estrogen plus progesterone treatment on apoptosis related genes in rat ovary.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Estradiol; Estrogens; Female; Gonadotropin-Releasing Hormone; Leuprolide; Norethindrone; Ovary; Progesterone; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction | 2009 |
Comparative performance of a combined injectable contraceptive (50 mg norethisterone enanthate plus 5mg estradiol valerate) and a combined oral contraceptive (0.15 mg levonorgestrel plus 0.03 mg ethinyl estradiol) in adolescents.
Topics: Adolescent; Ambulatory Care Facilities; Contraceptives, Oral, Combined; Drug Administration Schedule; Drug Combinations; Estradiol; Ethinyl Estradiol; Female; Humans; Injections, Intramuscular; Levonorgestrel; Medication Adherence; Norethindrone; Patient Satisfaction; Prospective Studies; Young Adult | 2009 |
Bone mineral density in a cohort of adolescents during use of norethisterone enanthate, depot-medroxyprogesterone acetate or combined oral contraceptives and after discontinuation of norethisterone enanthate.
Topics: Adolescent; Bone Density; Contraceptives, Oral, Combined; Delayed-Action Preparations; Female; Humans; Medroxyprogesterone Acetate; Norethindrone; Prospective Studies; Young Adult | 2009 |
Bone mineral density in young women aged 19-24 after 4-5 years of exclusive and mixed use of hormonal contraception.
Topics: Bone Diseases, Metabolic; Case-Control Studies; Contraceptives, Oral, Combined; Cross-Sectional Studies; Female; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Norethindrone; Time; Young Adult | 2009 |
Use of injectable progestin contraception and risk of STI among South African women.
Topics: Adolescent; Adult; Condoms; Female; Humans; Medroxyprogesterone Acetate; Multivariate Analysis; Norethindrone; Patient Selection; Pregnancy; Regression Analysis; Risk Factors; Sexually Transmitted Diseases, Bacterial; South Africa; Vaginitis | 2009 |
Prospective study of weight change in new adolescent users of DMPA, NET-EN, COCs, nonusers and discontinuers of hormonal contraception.
Topics: Adolescent; Body Mass Index; Body Weight; Contraception Behavior; Contraceptives, Oral, Combined; Female; Humans; Longitudinal Studies; Medroxyprogesterone Acetate; Norethindrone; Prospective Studies; Weight Gain; Withholding Treatment; Young Adult | 2010 |
Clinical experience with injectable progestogen- only contraceptives at University of Ilorin teaching hospital: a five year review.
Topics: Adult; Age Distribution; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Educational Status; Female; Hospitals, Teaching; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Menstruation Disturbances; Middle Aged; Nigeria; Norethindrone; Retrospective Studies; Risk Factors; Universities | 2009 |
Contraceptive options for women in selected circumstances.
Topics: Adolescent; Adult; Anemia; Breast Diseases; Cardiovascular Diseases; Condoms; Contraception; Contraceptive Agents, Female; Contraindications; Desogestrel; Diabetes Mellitus; Drug Combinations; Drug Implants; Epilepsy; Ethinyl Estradiol; Female; Heart Valve Diseases; Humans; Hypertension; Inflammatory Bowel Diseases; Injections; Intrauterine Devices; Levonorgestrel; Liver Diseases; Lupus Erythematosus, Systemic; Medroxyprogesterone Acetate; Migraine Disorders; Norethindrone; Norgestrel; Obesity; Patient Preference; Pregnancy; Progestins; Stroke; Young Adult | 2010 |
Assessing menopausal status in women aged 40 - 49 using depot-medroxyprogesterone acetate, norethisterone enanthate or combined oral contraception.
Topics: Adult; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Female; Follicle Stimulating Hormone; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norethindrone | 2011 |
Testosterone-induced prostate growth is blocked by co- and preadministration of norethisterone enanthate in castrated cynomolgus monkeys.
Topics: Animals; Biomarkers; Body Weight; Drug Administration Schedule; Hematocrit; Hormone Replacement Therapy; Macaca fascicularis; Male; Norethindrone; Orchiectomy; Organ Size; Progestins; Prostate; Testosterone; Time Factors | 2012 |
Experimental endocrine manipulation by contraceptive regimen in the male marmoset (Callithrix jacchus).
Topics: Animals; Antispermatogenic Agents; Body Weight; Callithrix; Chorionic Gonadotropin; Epididymis; Fertility; Male; Models, Animal; Norethindrone; Organ Size; Pituitary Gland; Ploidies; Sperm Motility; Testis; Testosterone | 2013 |
Next steps for research on hormonal contraception and HIV.
Topics: Contraception; Contraceptive Agents, Female; Female; HIV Infections; Humans; Medroxyprogesterone Acetate; Norethindrone; Randomized Controlled Trials as Topic; Risk Assessment | 2013 |
The effectiveness of community based distribution of injectable contraceptives using community health extension workers in Gombe State, Northern Nigeria.
Topics: Adolescent; Adult; Community Health Workers; Condoms; Condoms, Female; Contraceptive Agents, Female; Delivery of Health Care; Feasibility Studies; Female; Health Promotion; Humans; Injections; Male; Maternal Mortality; Medroxyprogesterone Acetate; Middle Aged; Nigeria; Norethindrone; Socioeconomic Factors | 2013 |
Highlights from the 21st CROI.
Topics: Animals; Anti-HIV Agents; Child; Contraceptive Agents, Female; Delayed-Action Preparations; Female; Hepatitis C; HIV Infections; Humans; Infant, Newborn; Male; Medication Adherence; Medroxyprogesterone Acetate; Norethindrone | 2014 |
Clinicians' perceptions and provision of hormonal contraceptives for HIV-positive and at-risk women in Southern Africa: an original research article.
Topics: Adult; Aged; Attitude of Health Personnel; Contraceptives, Oral; Contraceptives, Postcoital, Hormonal; Directive Counseling; Evidence-Based Medicine; Family Planning Services; Female; Health Care Surveys; HIV Seropositivity; Humans; Injections, Intramuscular; Male; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Practice Patterns, Nurses'; Practice Patterns, Physicians'; Risk Factors; South Africa; Young Adult; Zimbabwe | 2014 |
Injectable Progestin-Only Contraception is Associated With Increased Levels of Pro-Inflammatory Cytokines in the Female Genital Tract.
Topics: Adolescent; Adult; Contraception; Contraceptive Agents, Female; Cross-Sectional Studies; Cytokines; Female; Genitalia, Female; HIV Infections; Humans; Inflammation; Kenya; Medroxyprogesterone Acetate; Norethindrone; Pregnancy; Progestins; Sexually Transmitted Diseases, Bacterial; South Africa; Vaginosis, Bacterial; Young Adult | 2015 |
Norethisterone enanthate-induced cerebral venous sinus thrombosis (CVST).
Topics: Anticoagulants; Contraceptive Agents, Female; Female; Headache; Heparin; Humans; Injections, Intramuscular; Magnetic Resonance Imaging; Norethindrone; Parietal Lobe; Sinus Thrombosis, Intracranial; Young Adult | 2017 |
Impact of contraceptive initiation on vaginal microbiota.
Topics: Adult; Contraceptive Agents, Female; Desogestrel; DNA, Bacterial; Drug Implants; Ethinyl Estradiol; Female; Gardnerella vaginalis; Humans; Intrauterine Devices, Copper; Lactobacillus crispatus; Lactobacillus gasseri; Levonorgestrel; Medroxyprogesterone Acetate; Megasphaera; Microbiota; Norethindrone; Polymerase Chain Reaction; Protective Factors; Risk Factors; Vagina; Vaginosis, Bacterial; Young Adult | 2018 |
Depot medroxyprogesterone acetate and norethisterone enanthate differentially impact T-cell responses and expression of immunosuppressive markers.
Topics: Adolescent; Adult; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cells, Cultured; Contraceptive Agents, Female; CTLA-4 Antigen; Female; Humans; Immunophenotyping; Lymphocyte Activation; Medroxyprogesterone Acetate; Norethindrone; Programmed Cell Death 1 Receptor; Young Adult | 2020 |
Norethisterone Enanthate Increases Mouse Susceptibility to Genital Infection with Herpes Simplex Virus Type 2 and HIV Type 1.
Topics: Animals; Contraceptive Agents, Female; Desmoglein 1; Disease Susceptibility; Female; Herpes Genitalis; Herpesvirus 2, Human; HIV Infections; HIV-1; Medroxyprogesterone Acetate; Mice; Mice, Inbred C57BL; Mice, SCID; Mucous Membrane; Norethindrone; Permeability; Vagina | 2020 |